Report overview
This report aims to provide a comprehensive presentation of the global market for Preventable Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventable Vaccines. This report contains market size and forecasts of Preventable Vaccines in global, including the following market information:
Global Preventable Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Preventable Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Preventable Vaccines companies in 2022 (%)
The global Preventable Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Adult Preventable Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Preventable Vaccines include GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preventable Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preventable Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, by Type, 2022 (%)
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Global Preventable Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, by Application, 2022 (%)
Bacterial Diseases
Virus Diseases
Global Preventable Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preventable Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Preventable Vaccines revenues share in global market, 2022 (%)
Key companies Preventable Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Preventable Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Preventable Vaccines, market overview.
Chapter 2: Global Preventable Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Preventable Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Preventable Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Preventable Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
